Hoppa till innehåll
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Språk
Alla fält
Titel
Upphovsman
Ämne
Signum
ISBN/ISSN
Tagg
Sök
Avancerad
Outcomes after cessation of me...
Hänvisa
Textmeddelande
Skicka per e-post
Skriv ut
Exportera posten
Exportera till: RefWorks
Exportera till: EndNoteWeb
Exportera till: EndNote
Permanent länk
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
Visa andra versioner (2)
Bibliografiska uppgifter
Huvudupphovsmän:
Haldar, P
,
Brightling, C
,
Singapuri, A
,
Hargadon, B
,
Gupta, S
,
Monteiro, W
,
Bradding, P
,
Green, R
,
Wardlaw, A
,
Ortega, H
,
Pavord, I
Materialtyp:
Journal article
Publicerad:
2014
Beståndsuppgifter
Beskrivning
Andra versioner (2)
Liknande verk
Katalogiseringsuppgifter
Liknande verk
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
av: Haldar, P, et al.
Publicerad: (2014)
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
av: Haldar, P, et al.
Publicerad: (2014)
Mepolizumab and exacerbations of refractory eosinophilic asthma.
av: Haldar, P, et al.
Publicerad: (2009)
Mepolizumab in refractory eosinophilic asthma.
av: Pavord, I, et al.
Publicerad: (2010)
Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
av: Shrimanker, R, et al.
Publicerad: (2017)